Baseline, February 2018 (N=20) No. (%) | Endline, March 2019 (N=19) No. (%) | Net Percentage Gain | P Value p(2-tailed) | Risk Ratio | |
---|---|---|---|---|---|
Missed opportunity of vaccination | 7 (33%) | 5 (26%) | −7% | .7488 | 1.14 |
Side effect of pentavalent vaccine | 17 (85%) | 18 (95%) | 10% | .7488 | 0.33 |
Contraindications of vaccination | 3 (15%) | 17 (89%) | 74% | <.0001 | 0.13 |
Forecasting vaccine requirement | 2 (10%) | 15 (79%) | 69% | <.0001 | 0.23 |
Stages of vaccine vial monitor | 16 (80%) | 15 (84%) | 4% | 1.0000 | 1.05 |
Fridge tag | 9 (45%) | 11 (58%) | 13% | .5218 | 0.76 |
Defaulter tracking | 18 (90%) | 18 (95%) | 5% | 1.0000 | 0.50 |
EPI target estimation | 1 (5%) | 9 (47%) | 42% | .0104 | 0.55 |
Coverage rate calculation | 2 (10%) | 11 (58%) | 48% | .0039 | 0.46 |
Dropout rate calculation | 1(5%) | 14 (74%) | 69% | <.0001 | 0.27 |
Preparation of coverage monitor chart | 2 (10%) | 13 (68%) | 58% | .0004 | 0.34 |
Multidose vial policy | 4 (20%) | 5 (26%) | 6% | .7488 | 0.91 |
Abbreviation: Expanded Program on Immunization (EPI).
↵a Net percentage gain was calculated from the percentage of mentees who answered correctly the knowledge questions at baseline and endline. Significance (P value) was computed using McNemar's test with paired proportion of mentees' with correct knowledge on the topics at endline and baseline. Risk ratio was computed with probabilities of mentees' knowledge gap on the topics at endline and baseline.